Clinical Trials

Study Title

A phase II, observer-blind, randomized, controlled study to evaluate the immunogenicity and safety of a varicella vaccine at various potencies compared with Varivax, as a first dose, administered in healthy children in their second year of life. (VNS-GSK)

Purpose

To evaluate the immune response of new Varicella Vaccine and Varivax (currently used vaccine).

Eligibility

Study Process